Harmony Biosciences Holdings Inc
NASDAQ:HRMY

Watchlist Manager
Harmony Biosciences Holdings Inc Logo
Harmony Biosciences Holdings Inc
NASDAQ:HRMY
Watchlist
Price: 38.55 USD 1.8% Market Closed
Market Cap: 2.2B USD

Intrinsic Value

The intrinsic value of one HRMY stock under the Base Case scenario is 67.65 USD. Compared to the current market price of 38.55 USD, Harmony Biosciences Holdings Inc is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HRMY Intrinsic Value
67.65 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Harmony Biosciences Holdings Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about HRMY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HRMY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Harmony Biosciences Holdings Inc.

Explain Valuation
Compare HRMY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HRMY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harmony Biosciences Holdings Inc

Current Assets 838.8m
Cash & Short-Term Investments 672.6m
Receivables 100.7m
Other Current Assets 65.6m
Non-Current Assets 369.4m
Long-Term Investments 105.8m
PP&E 2.7m
Intangibles 95.4m
Other Non-Current Assets 165.5m
Current Liabilities 223.4m
Accounts Payable 26.3m
Accrued Liabilities 177.1m
Other Current Liabilities 20m
Non-Current Liabilities 149.7m
Long-Term Debt 148.5m
Other Non-Current Liabilities 1.2m
Efficiency

Free Cash Flow Analysis
Harmony Biosciences Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Harmony Biosciences Holdings Inc

Revenue
825.9m USD
Cost of Revenue
-184.2m USD
Gross Profit
641.7m USD
Operating Expenses
-416.1m USD
Operating Income
225.6m USD
Other Expenses
-40m USD
Net Income
185.7m USD
Fundamental Scores

HRMY Profitability Score
Profitability Due Diligence

Harmony Biosciences Holdings Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional Gross Margin
67/100
Profitability
Score

Harmony Biosciences Holdings Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

HRMY Solvency Score
Solvency Due Diligence

Harmony Biosciences Holdings Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
High Altman Z-Score
Low D/E
85/100
Solvency
Score

Harmony Biosciences Holdings Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HRMY Price Targets Summary
Harmony Biosciences Holdings Inc

Wall Street analysts forecast HRMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRMY is 47.11 USD with a low forecast of 32.32 USD and a high forecast of 65.1 USD.

Lowest
Price Target
32.32 USD
16% Downside
Average
Price Target
47.11 USD
22% Upside
Highest
Price Target
65.1 USD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Harmony Biosciences Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HRMY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HRMY Insider Trading
Buy and sell transactions by insiders

HRMY News

Other Videos
What is the Intrinsic Value of one HRMY stock?

The intrinsic value of one HRMY stock under the Base Case scenario is 67.65 USD.

Is HRMY stock undervalued or overvalued?

Compared to the current market price of 38.55 USD, Harmony Biosciences Holdings Inc is Undervalued by 43%.

Back to Top